Dementia

As a new age of weight-loss therapeutics dawns, scientists are one step closer to a drug that can coax muscles into behaving as if they’ve just been put through a workout. The benefits range from weight loss to treating diabetes and heart conditions.

There’s growing recognition that attention-deficit hyperactive disorder is not just a childhood disruptive behavior condition. Yet older adults, aged 50 and over, are not only consistently absent from ADHD studies, but face roadblocks in seeking help.

Physicists have combined nanotechnology, artificial intelligence and molecular biology to design a novel method that can detect Alzheimer’s disease protein markers in blood that are the tell-tale signs of early neurodegeneration.

A new study has found that over-60s with untreated high blood pressure have a greatly increased risk of developing dementia, suggesting that maintaining treatment for high blood pressure throughout later life is important for dementia prevention.

Turmeric can stain an amateur chef’s kitchen benches, hands and clothes bright yellow and has been a staple in traditional medicine for 4,000 years. Now, for the first time, a clinical trial suggests it can treat acid reflux as well as common medications.

Scientists have discovered how a unique kind of cell death, due to iron toxicity, creates a snowball effect that advances cognitive decline. With this finding, a whole new approach to treatment could be developed.

In an effort to find new treatments to halt the progression of Alzheimer's disease, scientists have landed on a molecule that can dial down the process that produces brain inflammation – something believed to be inextricably linked to cognitive decline.

Researchers have developed a new risk 'calculator' that identifies people in midlife at risk of developing dementia in the next 14 years. Moreover, it's based on 11 key risk factors, many of them modifiable.

A study has found that some gastrointestinal disorders are associated with an increased risk of developing Parkinson’s disease. The research provides further evidence to support the hypothesis that the neurodegenerative disorder begins in the gut.

The US Food and Drug Administration recently fast-tracked its approval of brexpiprazole (Rexulti), an antipsychotic for treating agitation in dementia patients, when clinical studies demonstrated an increased risk of death and no meaningful benefit.

Six million Americans are living with Alzheimer’s disease, and with it comes the physical behaviors that are responsible for 80% of nursing home admissions. Researchers believe fasting set to circadian rhythms could alleviate these awful side effects.

A study last year found that the influenza vaccine reduced the risk of Alzheimer's disease. Now, the same research team has found that people aged 65 and over who’ve received routine vaccinations are significantly less likely to develop the condition.